MultiCell Technologies, Inc.: 10-Q filed 2015-04-14
What MultiCell Technologies, Inc. reported in its quarterly report filed 2015-04-14 (fiscal Q1 2015): 22 published measures, 48 facts as tagged in accession 0001144204-15-022738.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-04-14
- Fiscal period
- fiscal Q1 2015
- Accession
- 0001144204-15-022738 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All MultiCell Technologies, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 66,100 | USD | |
| At 2014-11-30 | 126,223 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 1,783,425 | USD | |
| At 2014-11-30 | 1,643,397 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | -326,562 | USD | |
| At 2014-11-30 | -144,276 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 53,828 | USD | |
| At 2014-11-30 | 112,533 | USD | |
| At 2014-02-28 | 240,965 | USD | |
| At 2013-11-30 | 146,205 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | -262,289 | USD | 90 |
| 2013-12-01 to 2014-02-28 | -280,258 | USD | 90 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | -49,422,884 | USD | |
| At 2014-11-30 | -46,134,117 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 0 | USD | |
| At 2014-11-30 | 0 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 3,003 | USD | 90 |
| 2013-12-01 to 2014-02-28 | 42,012 | USD | 90 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | -288,877 | USD | 90 |
| 2013-12-01 to 2014-02-28 | -309,493 | USD | 90 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 65,820 | USD | |
| At 2014-11-30 | 125,943 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 595 | USD | 90 |
| 2013-12-01 to 2014-02-28 | 700 | USD | 90 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 1,379,230 | USD | |
| At 2014-11-30 | 1,181,134 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 301,206 | USD | 90 |
| 2013-12-01 to 2014-02-28 | 321,822 | USD | 90 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 251,998 | USD | 90 |
| 2013-12-01 to 2014-02-28 | 213,556 | USD | 90 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 46,205 | USD | 90 |
| 2013-12-01 to 2014-02-28 | 66,254 | USD | 90 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 4,863,448,700 | shares | |
| At 2014-11-30 | 4,552,800,552 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 0 | USD | |
| At 2014-11-30 | 0 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | -1,717,325 | USD | |
| At 2014-11-30 | -1,517,174 | USD | |
| At 2014-02-28 | -1,615,149 | USD | |
| At 2013-11-30 | -1,567,421 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 40,166 | USD | |
| At 2014-11-30 | 40,166 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-02-28 | 280 | USD | |
| At 2014-11-30 | 280 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | -280,154 | USD | 90 |
| 2013-12-01 to 2014-02-28 | -317,440 | USD | 90 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-12-01 to 2015-02-28 | 8,723 | USD | 90 |
| 2013-12-01 to 2014-02-28 | -7,947 | USD | 90 |
Inspect the source
- Entity
- MultiCell Technologies, Inc. / CIK 0000811779
- Captured
- SEC response SHA-256
2b6a8e9a4a33753adc101e5ddc18ac1b28909ef6fe913ab8b01ee77bcedbc4cb
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000811779.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))